Sutro Biopharma
STRO
STRO
62 hedge funds and large institutions have $64.8M invested in Sutro Biopharma in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
28% less funds holding
Funds holding: 86 → 62 (-24)
40% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 25
66% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 32
Holders
62
Holding in Top 10
2
Calls
$35K
Puts
$8K
Top Buyers
| 1 | +$6.39M | |
| 2 | +$2.18M | |
| 3 | +$1.81M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.7M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$700K |
Top Sellers
| 1 | -$5.63M | |
| 2 | -$1.68M | |
| 3 | -$1.36M | |
| 4 |
BlackRock
New York
|
-$487K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$387K |
